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47
Chlamydia trachomatis is estimated to infect 100 million people annually causing chronic 48 genital and ocular infections [1] . The course of genital infection is mostly asymptomatic 49 leaving the infection undiagnosed and untreated. Untreated genital chlamydial infection can 50 cause severe tissue damage and lead to pelvic inflammatory disease, ectopic pregnancy, and 51 infertility [2] . 52 C. trachomatis is an obligate intracellular Gram-negative bacterium with a unique biphasic 53 developmental cycle. The infectious, but metabolic inactive elementary body (EB) infects 54 epithelial cells in the genital mucosa. Intracellularly, the EB transforms to a larger non-55 infectious but metabolic active reticulate body (RB) [3] . During entry, C. trachomatis inhibits 56 phagosome-lysosome fusion and resides in a modified vacuole called an inclusion, which 57 provides a niche for bacterial replication [4] . 58
Chlamydial infections tend to be chronic even though both humoral and cell-mediated 59 immunity are elicited [5] . Monocytes and macrophages play essential roles in anti-bacterial 60 immunity in general, but little is known about the exact role of monocytes during C. 61 trachomatis infections. During infection, epithelial cells respond by secreting several 62 cytokines and chemokines creating a local inflammatory condition that recruits monocytes to 63 the site of infection [6] . In vitro studies show that several C. trachomatis serovars infect 64 human monocytes inducing cellular activation with secretion of inflammatory cytokines, such 65 as IL-1β, IL-6, and IL-8 [7] . Chlamydial uptake into host cells is supposedly carried out by 66 phagocytosis or by receptor-mediated endocytosis, but the exact mechanisms and the 67 M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4
The complement system consists of more than 30 different proteins comprising both soluble 72 factors and cell surface receptors [13] . Complement activation initiates a cascade of 73 proteolytic cleavages leading to both direct and indirect anti-microbial effects. The direct anti-74 microbicidal functions are carried out by the membrane attack complex (MAC), a pore-75 formed structure consisting of repetitive membrane-spanning complement factors that causes 76 membrane permeability and cellular lysis. Another function of the complement system is 77 mediated by the so-called opsonins, which bind to the surface of pathogens tagging them for 78 uptake and degradation in professional phagocytes. 79
The complement system is mainly activated through three distinct pathways which are 80 triggered by different structural motifs and involve different intermediate complement 81
products, but they all converge at the common downstream effector C3 convertase. C3 82 convertase cleaves complement factor C3 into the anaphylatoxin C3a and the opsonin C3b. 83
C3b may be further cleaved into additional opsonins called iC3b and C3dg. C3b, iC3b, and 84
C3dg are all recognized by surface receptors expressed on different host immune cells and 85 opsonin-receptor engagement leads to receptor-mediated phagocytosis of the opsonized 86 organism. It has been shown that C3b and iC3b are recognized by complement receptor (CR) 87 1 and CR3, respectively, and both receptors are ubiquitously expressed on monocytes and 88 macrophages and are important for mononuclear phagocytosis of infectious bacteria [14] . 89 C. trachomatis is able to activate the complement system and it has been demonstrated that C. 90 trachomatis induced complement activation leads to binding of C3 to the bacterium [15] . 91
To further explore the interaction between the complement system and C. trachomatis, we 92 investigated how complement deposition on C. trachomatis affects the uptake of chlamydial 93
EBs into human monocytes and how complement modulates the intracellular fate of C. 94 trachomatis in monocytes. Uncovering new aspects of the interaction between complement, Immunofluorescence staining was carried out essentially according to Carlsen et al. [21] . 146
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Extracellular bacteria and surface bound CD11b were stained prior to fixation by incubating 147 cells for 30 minutes at 37 °C with Pab17 (1:200) or anti-CD11b (5 µg/ml) diluted in PBS 148 containing 0.1% bovine serum albumin (BSA) and 0.05% sodium azide. Cells were washed 149 twice in PBS and fixed for 20 minutes in 3.7% formaldehyde at 4 °C. Cells were 150 permeabilized for 7 minutes in 0.2% Triton-X 100 at room temperature and blocked in 0.1% 151 BSA for 15 minutes at 37 °C. Primary antibodies were diluted in antibody buffer containing 152 0.1% BSA in PBS (Mab32.3: 5 µg/ml) and cells were incubated with primary antibody for 30 153 minutes at 37 °C. Cells were washed three times in antibody buffer and incubated with 154 secondary antibodies diluted 1:200 in antibody buffer. Cells were washed three times in 155 antibody buffer and counter-stained with either 2 µM To-Pro-3 Iodide or 2 µM DAPI for 10 156 minutes at room temperature. Finally, mounting medium was added to each well and slides 157 were mounted with cover slips. 158
Cells were visualized and imaged using a Leica SP5 confocal microscope or a Leica DM 159 5500 B fluorescence microscope. 160 161
Immunoelectron microscopy 162
Purified EBs were mixed with 1/10 volume of NHS or HIHS. Five microL purified EB was 163 added to the surface of carbon-coated glow discharged 400 mesh nickel grids as described 164 (20). The grids were washed on three drops of PBS (pH 6.5) and blocked on one drop of 1% 165 ovalbumin (Sigma-Aldrich) in PBS. The grids were then incubated for 30 min at 37 °C with 166 1/200 rabbit anti-C3c antibody (Agilent Technologies) diluted in ovalbumin. The grids were 167 then washed on three drops PBS and incubated for 30 min at 37 °C in goat anti-rabbit 168 antibodies conjugated with 10 nm colloidal gold (1:25) in ovalbumin. Following this, the 169 grids were washed on three drops of PBS, incubated on three drops 0.5% cold fish gelatin We aimed to investigate whether complement components affect the uptake of C. trachomatis 220 into monocytes. First, dilutions of C. trachomatis D and L2 were titrated to obtain an average 221 Chlamydia-to-monocyte ratio of 1. Intracellular chlamydiae were visualized using a 222 monoclonal antibody against chlamydial MOMP (Fig. 1A) . The intracellular localization in 223 monocytes were confirmed both by membrane staining against CD11b and by differential 224 when chlamydial EBs were incubated with HIHS, only few gold particles were observed on 247 the EB surface (Fig. 2B, F) . No gold was observed on the EB surface when EBs were 248 incubated with NHS and anti-C3c was omitted (Fig. 2C, G) . To quantify complement 249 deposition, bacteria associated gold particles and gold particles associated with the 250 background were enumerated and these numbers were expressed as a ratio. Fig. 2D+H show 251 that more gold particles are deposited on the bacterial surface when incubated with NHS 252 compared to HIHS. Thus, complement factors containing the C3c domain bind to the surface 253 of C. trachomatis D and L2 in the presence of NHS, but not HIHS, and this may account for 254 the observed differences in uptake efficiency. 255 256
Investigation of Chlamydia-bound C3 257
By immune-gold electron microscopy we confirmed that complement C3 fragments bind to 258 the surface of C. trachomatis D and L2 EBs. However, since C3c is a common structure 259 found in different C3 fragments we could not elucidate exactly which fragments were bound 260 to the EBs or if activation of the cleavage cascade had occurred. 261
We therefore conducted an immunoblot analysis of purified chlamydial EBs incubated in 262 either NHS or HIHS. Western blotting was performed three times using different sera with 263 similar results and a representative blot is shown in Fig. 3A. Fig. 3A shows that uncleaved α 264 and β chains of C3 (119 and 74 kDa, respectively) were present on EB after incubation with 265 either NHS or HIHS, though much stronger when incubated with NHS. Several other C3 266 protein bands were bound to both C. trachomatis D and L2 when incubated in NHS. The 267 protein band observed around 45 kDa corresponds to the α'2 fragment of C3 which is only 268 found in complement iC3b (Fig. 3B) . These findings showed that the complement cascade is M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
only activated in NHS leading to production and binding of iC3b to both C. trachomatis D 270 and L2. In addition to the protein bands just described, two protein bands were present in the 271 high molecular area (165 and 250 kDa, respectively) in the lanes in which EB were incubated 272 with NHS (Fig. 3A) . These bands represent fragments of either the α' chain of C3b or the α´1 273 chain of iC3b covalently linked to unidentified proteins. Both chains contain an exposed 274 thioester site that allows covalent interactions between C3b/iC3b and target proteins (Fig.  275   3B) . 
Complement C3 facilitated uptake of C. trachomatis into monocytes 280
The above results suggest that C3 opsonization of C. trachomatis could explain the 281 differential uptake efficiency observed using complement-competent serum and heat-282 inactivated serum, respectively. To elucidate whether C3 in fact facilitates uptake into 283 monocytes, we investigated the monocyte uptake of C. trachomatis L2 in the presence C3-284 depleted human serum after one hour of incubation Fig. 4 . shows that using C3-depleted 285 serum reduces the uptake of chlamydia into monocytes compared to bacteria incubated in the 286 presence of NHS. Adding purified human C3 to the C3-depleted serum restored the monocyte 287 uptake efficiency, demonstrating that complement C3 facilitates uptake of C. trachomatis into 288 monocytes. 289 290
Intracellular fate of C. trachomatis after complement-mediated monocyte ingestion 291
As early uptake of C. trachomatis in monocytes is facilitated by complement C3 292 opsonization, we analyzed the fate of C. trachomatis when ingested by monocytes to 293 elucidate the biological significance of the rapid uptake. 
Complement modulation of C. trachomatis induced cytokine production 313
We showed that complement C3 potentiates the chlamydial uptake, and that uptake leads to 314 efficient intracellular killing of the bacteria, which is one of the primary roles of monocytes 315 
Discussion
333
We demonstrated that purified EBs of the two serovars, D and L2, of C. trachomatis activated 334 the complement system leading to deposition of C3 fragments on the chlamydial surface and 335 that complement C3 facilitates rapid chlamydial uptake into human primary monocytes 336 leading to bacterial elimination and cytokine production. To our knowledge, we are the first to demonstrate direct involvement of complement C3 in 343 monocyte ingestion of C. trachomatis and that complement C3 is deposited on the surface of 344 C. trachomatis D EBs. Additionally, using immunoelectron microscopy, we directly 345 visualized complement deposition on serovar L2 previously reported by Hall et al. [15] . We 346 found that complement was activated generating iC3b which was bound to the surface of both 347 serovar D and L2. iC3b is a potent opsonin that has been involved in opsonization and 348 phagocytosis of other intracellular bacteria such as M. tuberculosis [25] . CD14-dependent recruitment of CR3 to lipid rafts, suggesting that CD14 may also be 357 involved in the enhanced uptake, since CD14 is widely expressed on monocytes [31, 32] . 358
Thus, it seems likely that the enhanced uptake of C. trachomatis observed in NHS is due to 359 iC3b-mediated phagocytosis by CR3 engagement. However, iC3b is not exclusively 360 recognized by CR3. CR1 and CR4 can also bind iC3b leading to iC3b-mediated phagocytosis 361
An important parameter to discuss in this context is the involvement of the complement 363 anaphylatoxins C3a and C5a, which are generated by proteolytic cleavage of C3 and C5 364 during complement activation. These inflammatory mediators were not investigated in the 365 current study, but we demonstrate C3 cleavage and, therefore, we know that C3a is generated. 366
Although some degree of C3b inactivation was observed, it is likely that the complement A unique feature of C3 opsonins is their ability to covalently attach to target structures 378 through a thioester site located in the α' chain of C3b and in the α'1 chain of iC3b (Fig. 3B) . 379
Our data suggest that iC3b is covalently attached to protein structures on both serovars since 380 several high molecular protein bands are observed under both denaturing and reducing 381
conditions. Under reducing conditions iC3b will split into three protein fragments: α'1 (63 382 kDa), α'2 (39 kDa), and β (75 kDa) [36] . We observe the latter two, but not the α'1 fragment. 383
The α'1 fragment is likely located in the observed high molecular bands covalently attached 384 to other proteins. It was previously proposed that C3 fragments interact with MOMP on the 385 chlamydial surface, but it was not conclusively determined due to antibody cross-reactivity 386
[15]. We observed anti-C3c reactive protein bands migrating approximately at 165 and 250 387 kDa, which does not correspond to the summed molecular mass of MOMP and the α'1 388 fragment (40 kDa + 110 kDa, respectively). The protein bands observed around 250 kDa 389 suggest that iC3b interacts with high molecular weight surface structures. Potential high 390 molecular candidates to interact with C3 are the polymorphic membrane proteins, which 391 ranges in size from 95 kDa to 187 kDa, however this was not further investigated. 392 M A N U S C R I P T
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We used immunoelectron microscopy to directly visualize protein deposition on the EB 393 surface. Interestingly, we observed that the C3 fragments were loosely bound to the 394 chlamydial surface and this observation does not fit with the idea that C3 is covalently linked 395 to chlamydial outer membrane proteins, however, several chlamydial-complement bindings 396 may be involved. It has been demonstrated that LPS is loosely bound in the chlamydial outer 397 membrane and we observed a very similar gold-labelling pattern that could suggest that C3 398 also interacts with non-protein structures like LPS, which has been demonstrated for other 399 bacteria previously [22, 37] . 400
The loosely attachment of complement to the bacterial surface may be advantageous to the 401 bacterium allowing some degree of complement shedding which can reduce the rapid 402 recognition and ingestion by phagocytes. Thus, complement binding to C. trachomatis EBs 403 may involve interactions with both protein structures and LPS on the bacterial surface. 404
405
We showed that uptake of C. trachomatis was accompanied by rapid inactivation and 406 elimination of the bacteria inside monocytes. In our experiments, no viable chlamydiae were 407 recovered after 24 hours inside monocytes even though chlamydia could still be detected by 408 immunofluorescence staining against MOMP at this time (data not shown). This demonstrates 409 the limitation of antibodies as a detection tool when questions regarding bacterial viability is 410 addressed. Under these circumstances, it is important to include functional assays or include 411 analyses of bacterial metabolites that can highlight important differences in bacterial viability. 412
There is some ambiguity related to the fate of C. trachomatis in monocytes and macrophages. 413
In murine macrophages C. trachomatis L2 is rapidly directed to destructive intracellular 414 compartments including both lysosomes and autophagosomes [38] . However, a study using 415 primary human monocytes showed that C. trachomatis can remain viable and infectious after 416 
